Your browser doesn't support javascript.
loading
Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.
Fontanals-Cirera, Barbara; Hasson, Dan; Vardabasso, Chiara; Di Micco, Raffaella; Agrawal, Praveen; Chowdhury, Asif; Gantz, Madeleine; de Pablos-Aragoneses, Ana; Morgenstern, Ari; Wu, Pamela; Filipescu, Dan; Valle-Garcia, David; Darvishian, Farbod; Roe, Jae-Seok; Davies, Michael A; Vakoc, Christopher R; Hernando, Eva; Bernstein, Emily.
Affiliation
  • Fontanals-Cirera B; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Hasson D; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Vardabasso C; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Di Micco R; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Agrawal P; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Chowdhury A; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gantz M; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • de Pablos-Aragoneses A; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Morgenstern A; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Wu P; Institute of Systems Genetics, New York University Langone Medical Center, New York, NY, USA.
  • Filipescu D; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Valle-Garcia D; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Darvishian F; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA.
  • Roe JS; Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY, USA.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vakoc CR; Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY, USA.
  • Hernando E; Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA. Electronic address: eva.hernando-monge@nyumc.org.
  • Bernstein E; Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: emily.bernstein@mssm.edu.
Mol Cell ; 68(4): 731-744.e9, 2017 Nov 16.
Article in En | MEDLINE | ID: mdl-29149598

Full text: 1 Database: MEDLINE Main subject: Enhancer Elements, Genetic / Melanoma / Neoplasm Proteins / Nerve Tissue Proteins / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Enhancer Elements, Genetic / Melanoma / Neoplasm Proteins / Nerve Tissue Proteins / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2017 Type: Article Affiliation country: United States